- cafead   Nov 17, 2020 at 11:22: PM
via A little less than a week after beefing up the data package it plans to take to the FDA for the experimental HIV drug cabotegravir, GSK-owned ViiV Healthcare has received good news on the medicine’s prospects.
article source
article source